These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9637502

  • 21. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
    Obermeier F, Dunger N, Deml L, Herfarth H, Schölmerich J, Falk W.
    Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
    [Abstract] [Full Text] [Related]

  • 22. CpG-ODN increases resistance of olive flounder (Paralichthys olivaceus) against Philasterides dicentrarchi (Ciliophora: Scuticociliatia) infection.
    Lee EH, Kim KH.
    Fish Shellfish Immunol; 2009 Jan; 26(1):29-32. PubMed ID: 18992348
    [Abstract] [Full Text] [Related]

  • 23. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L, Jiang W, Ding G, Cao H, Lu Y, Luo P, Zhou H, Zheng J.
    Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
    [Abstract] [Full Text] [Related]

  • 24. Activation of natural killer-like YT-INDY cells by oligodeoxynucleotides and binding by homologous pattern recognition proteins.
    Kaur H, Jaso-Friedmann L, Leary JH, Praveen K, Brahmi Z, Evans DL.
    Scand J Immunol; 2005 Oct; 62(4):361-70. PubMed ID: 16253123
    [Abstract] [Full Text] [Related]

  • 25. CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-kappaB activation.
    Lee S, Hong J, Choi SY, Oh SB, Park K, Kim JS, Karin M, Lee SJ.
    J Neuroimmunol; 2004 Aug; 153(1-2):50-63. PubMed ID: 15265663
    [Abstract] [Full Text] [Related]

  • 26. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
    Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM.
    Eur J Immunol; 2004 Jan; 34(1):251-62. PubMed ID: 14971051
    [Abstract] [Full Text] [Related]

  • 27. Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats.
    Svelander L, Erlandsson Harris H, Lorentzen JC, Trollmo C, Klareskog L, Bucht A.
    Arthritis Rheum; 2004 Jan; 50(1):297-304. PubMed ID: 14730628
    [Abstract] [Full Text] [Related]

  • 28. Induction of immune activation by a novel immunomodulatory oligonucleotide without thymocyte apoptosis.
    Jiang W, Reich CF, You D, Kandimalla E, Agrawal S, Pisetsky DS.
    Biochem Biophys Res Commun; 2004 May 21; 318(1):60-6. PubMed ID: 15110753
    [Abstract] [Full Text] [Related]

  • 29. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G, Flora M, Chattopadhyay G, Klinman DM, Lees A, Mond JJ, Snapper CM.
    Cell Immunol; 2004 May 21; 232(1-2):64-74. PubMed ID: 15922717
    [Abstract] [Full Text] [Related]

  • 30. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells.
    Wattrang E.
    Vet Immunol Immunopathol; 2009 Oct 15; 131(3-4):218-28. PubMed ID: 19447503
    [Abstract] [Full Text] [Related]

  • 31. CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysis.
    Klaschik S, Gursel I, Klinman DM.
    Mol Immunol; 2007 Feb 15; 44(6):1095-104. PubMed ID: 16930709
    [Abstract] [Full Text] [Related]

  • 32. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R, Roberts TL, Stacey KJ, Lenert P.
    Eur J Immunol; 2006 Jul 15; 36(7):1951-62. PubMed ID: 16791898
    [Abstract] [Full Text] [Related]

  • 33. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4.
    Illera VA, Perandones CE, Stunz LL, Mower DA, Ashman RF.
    J Immunol; 1993 Sep 15; 151(6):2965-73. PubMed ID: 8376764
    [Abstract] [Full Text] [Related]

  • 34. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS.
    Clin Cancer Res; 2005 Aug 15; 11(16):5950-5. PubMed ID: 16115938
    [Abstract] [Full Text] [Related]

  • 35. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 15; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ, Schrader AJ, Simon C, Dalpke A, Barth P, Hofmann R, Hegele A.
    Anticancer Res; 2009 Jun 15; 29(6):2067-76. PubMed ID: 19528466
    [Abstract] [Full Text] [Related]

  • 37. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C, Pastorino F, Marimpietri D, Pagnan G, Pistorio A, Allen TM, Pistoia V, Ponzoni M.
    J Natl Cancer Inst; 2004 Aug 04; 96(15):1171-80. PubMed ID: 15292389
    [Abstract] [Full Text] [Related]

  • 38. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK, Weiner GJ.
    J Leukoc Biol; 2005 Mar 04; 77(3):378-87. PubMed ID: 15582984
    [Abstract] [Full Text] [Related]

  • 39. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S.
    Eur J Immunol; 2003 Jun 04; 33(6):1633-41. PubMed ID: 12778481
    [Abstract] [Full Text] [Related]

  • 40. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
    Bleich A, Janus LM, Smoczek A, Westendorf AM, Strauch U, Mähler M, Hedrich HJ, Fichtner-Feigl S, Schölmerich J, Falk W, Hofmann C, Obermeier F.
    Gastroenterology; 2009 Jan 04; 136(1):278-87. PubMed ID: 18952084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.